Northern Trust
CYCN icon

Northern Trust’s Cyclerion Therapeutics CYCN Stock Holding History

Northern Trust’s Portfolio CYCN Stock Details CYCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,040
Closed -$35.1K – 4545
2023
Q1 		$35.1K Hold
4,040
– – ﹤0.01% 4345
2022
Q4 		$53K Hold
4,040
– – ﹤0.01% 4270
2022
Q3 		$69K Hold
4,040
– – ﹤0.01% 4229
2022
Q2 		$44K Hold
4,040
– – ﹤0.01% 4441
2022
Q1 		$90K Hold
4,040
– – ﹤0.01% 4380
2021
Q4 		$139K Buy
4,040
+446
+12% +$21.1K ﹤0.01% 4320
2021
Q3 		$220K Buy
3,594
+363
+11% +$23.8K ﹤0.01% 4133
2021
Q2 		$252K Sell
3,231
-8,720
-73% -$546K ﹤0.01% 4054
2021
Q1 		$667K Sell
11,951
-901
-7% -$67.7K ﹤0.01% 3734
2020
Q4 		$787K Sell
12,852
-453
-3% -$30.9K ﹤0.01% 3600
2020
Q3 		$1.62M Buy
13,305
+983
+8% +$112K ﹤0.01% 3154
2020
Q2 		$1.46M Sell
12,322
-1,365
-10% -$114K ﹤0.01% 3197
2020
Q1 		$725K Sell
13,687
-661
-5% -$47.2K ﹤0.01% 3343
2019
Q4 		$780K Buy
14,348
+183
+1% +$17.1K ﹤0.01% 3465
2019
Q3 		$3.43M Buy
14,165
+4,657
+49% +$1.01M ﹤0.01% 2774
2019
Q2 		$2.18M Buy
+9,508
New +$2.69M ﹤0.01% 3045

Other funds holding CYCN

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Northern Trust's CYCN Position: Q2 2023 in Review

Northern Trust sold out of Cyclerion Therapeutics (CYCN) in Q2 2023, closing a stake of 4,040 shares — an estimated $35.1K sold.

Northern Trust first reported a position in CYCN in Q2 2019 and held it in 16 quarters. The position peaked at $3.43M in Q3 2019. 18 funds tracked by Wall St. Rank hold CYCN as of Q2 2023.

  • Northern Trust reported no remaining Cyclerion Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Northern Trust sold 4,040 Cyclerion Therapeutics shares in Q2 2023, an estimated $35.1K.
  • Northern Trust first reported a position in Cyclerion Therapeutics in Q2 2019 and held it in 16 quarters.
  • Northern Trust's Cyclerion Therapeutics position peaked at $3.43M in Q3 2019.
  • 18 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q2 2023.

Based on Northern Trust's 13F filing for Q2 2023, filed 11 Aug 2023.